MAYO CLINIC
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Intestinal Permeability and Gastroparesis
Not Applicable
Withdrawn
- Conditions
- GastroparesisHealthy
- Interventions
- Diagnostic Test: Labs, urine tests, upper endoscopy with biopsy and confocal laser endomicroscopy
- First Posted Date
- 2021-05-20
- Last Posted Date
- 2023-04-19
- Lead Sponsor
- Mayo Clinic
- Registration Number
- NCT04894656
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies
Phase 1
Recruiting
- Conditions
- Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Small Lymphocytic LymphomaRefractory Transformed Chronic Lymphocytic LeukemiaRecurrent Chronic Lymphocytic LeukemiaRefractory B-Cell Non-Hodgkin LymphomaRefractory Small Lymphocytic LymphomaRecurrent Transformed Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia
- Interventions
- Biological: Autologous Anti-CD19 CAR-expressing T-lymphocytes IC19/1563Drug: BendamustineProcedure: Biospecimen CollectionProcedure: Bone Marrow AspirationProcedure: Bone Marrow BiopsyProcedure: Computed TomographyDrug: CyclophosphamideDrug: FludarabineProcedure: Magnetic Resonance ImagingProcedure: Positron Emission Tomography
- First Posted Date
- 2021-05-19
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 25
- Registration Number
- NCT04892277
- Locations
- πΊπΈ
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Virtual Reality in Electrophysiology Laboratory (EP)
- Conditions
- PVC - Premature Ventricular ComplexAblation
- Interventions
- Other: Virtual reality
- First Posted Date
- 2021-05-19
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 10
- Registration Number
- NCT04893278
- Locations
- πΊπΈ
Mayo Clinic in Florida, Jacksonville, Florida, United States
Belantamab Mafodotin, Lenalidomide, and Daratumumab for the Treatment of Relapsed, Refractory, or Previously Untreated Multiple Myeloma
Phase 1
Completed
- Conditions
- Plasma Cell MyelomaRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
- Interventions
- Biological: Belantamab MafodotinBiological: DaratumumabDrug: LenalidomideDrug: DexamethasoneOther: Quality-of-Life AssessmentProcedure: Biospecimen CollectionProcedure: Skeletal Survey X-RayProcedure: Low Dose Computed Tomography of the Whole BodyProcedure: Bone Marrow AspirationProcedure: Bone Marrow Biopsy
- First Posted Date
- 2021-05-19
- Last Posted Date
- 2024-03-29
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 5
- Registration Number
- NCT04892264
- Locations
- πΊπΈ
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Platelet-rich Plasma for Thumb Carpometacarpal Joint Osteoarthritis
Completed
- Conditions
- Thumb Carpometacarpal Joint Osteoarthritis
- First Posted Date
- 2021-05-14
- Last Posted Date
- 2021-05-14
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 170
- Registration Number
- NCT04886349
- Locations
- πΊπΈ
Mayo Clinic, Rochester, Minnesota, United States
COVID-19 Infection in Patients Receiving Anti-CD20 Therapy
Completed
- Conditions
- COVID-19Immunosuppressed HostAnti-CD20 TherapyConvalescent Plasma
- Interventions
- Biological: Convalescent Plasma
- First Posted Date
- 2021-05-13
- Last Posted Date
- 2023-03-01
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 342
- Registration Number
- NCT04884477
- Locations
- πΊπΈ
Mayo Clinic, Rochester, Minnesota, United States
Post-Surgical Based Efforts to Reduce Preventable Readmissions and Optimize Length of Stay
Not Applicable
Completed
- Conditions
- Surgery
- Interventions
- Device: Remote Monitoring
- First Posted Date
- 2021-05-11
- Last Posted Date
- 2022-07-08
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 300
- Registration Number
- NCT04881708
- Locations
- πΊπΈ
Mayo Clinic in Rochester, Rochester, Minnesota, United States
A Study to Evaluate Non-significant Risk Operation Magnetic Resonance Imaging for MRI Guided Ablation
Not Applicable
Recruiting
- Conditions
- Healthy
- Interventions
- Device: Magnetic Resonance Imaging (MRI)
- First Posted Date
- 2021-05-10
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 100
- Registration Number
- NCT04880226
- Locations
- πΊπΈ
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Ultra-low-dose Chest CT for HHT
Active, not recruiting
- Conditions
- Hereditary Hemorrhagic Telangiectasia
- Interventions
- Diagnostic Test: Ultra-low dose chest CT
- First Posted Date
- 2021-05-05
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 10
- Registration Number
- NCT04874558
- Locations
- πΊπΈ
Mayo Clinic in Rochester, Rochester, Minnesota, United States
A Study to Improve Diabetes Management Among Adults Experiencing Severe Hypoglycemia
Not Applicable
Suspended
- Conditions
- HypoglycemiaDiabetesDiabetes Type 1Diabetes Type 2
- Interventions
- Other: Community Paramedic ProgramOther: Education Material
- First Posted Date
- 2021-05-05
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 150
- Registration Number
- NCT04874532
- Locations
- πΊπΈ
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Β© Copyright 2025. All Rights Reserved by MedPath